Compound ID | 163
MRX-II
Class: Oxazolidinone
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Protein synthesis inhibitor |
| Target Pathogen: | Active against Gram-positive infections including methicillin-resistant Staphylococcus aureus |
| Description: | Synthetic compound |
| Institute where first reported: | MicuRx Pharmaceuticals, USA |
| Year first mentioned: | 2015 |
| Highest development stage: | Preclinical |
| Development status: | Experimental |
| External links: |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.